Cargando…
REDOR NMR Reveals Multiple Conformers for a Protein Kinase C Ligand in a Membrane Environment
[Image: see text] Bryostatin 1 (henceforth bryostatin) is in clinical trials for the treatment of Alzheimer’s disease and for HIV/AIDS eradication. It is also a preclinical lead for cancer immunotherapy and other therapeutic indications. Yet nothing is known about the conformation of bryostatin boun...
Autores principales: | Yang, Hao, Staveness, Daryl, Ryckbosch, Steven M., Axtman, Alison D., Loy, Brian A., Barnes, Alexander B., Pande, Vijay S., Schaefer, Jacob, Wender, Paul A., Cegelski, Lynette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785774/ https://www.ncbi.nlm.nih.gov/pubmed/29392180 http://dx.doi.org/10.1021/acscentsci.7b00475 |
Ejemplares similares
-
The Application of REDOR NMR to Understand the Conformation of Epothilone B
por: Lee, Jae-Ho, et al.
Publicado: (2017) -
Improved Protein Kinase C Affinity through Final Step
Diversification of a Simplified Salicylate-Derived Bryostatin Analog
Scaffold
por: Wender, Paul A., et al.
Publicado: (2014) -
Monitoring tat peptide binding to TAR RNA by solid-state (31)P–(19)F REDOR NMR
por: Olsen, Greg L., et al.
Publicado: (2005) -
Three Decades of REDOR in Protein Science: A Solid-State NMR Technique for Distance Measurement and Spectral Editing
por: Toke, Orsolya
Publicado: (2023) -
Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes
por: Ryckbosch, Steven M., et al.
Publicado: (2017)